- Indaptus Therapeutics press release (NASDAQ:INDP): Q3 GAAP EPS of -$0.42 beats by $0.09.
- As of September 30, 2022, the company had cash, cash equivalents and marketable securities of approximately $28.5 million.
- As of December 31, 2021, the Company had cash and cash equivalents of approximately $39.1 million.
- The Company expects that its current cash, cash equivalents and marketable securities will support its ongoing operating activities into the second quarter of 2024.
Indaptus Therapeutics GAAP EPS of -$0.42 beats by $0.09
Recommended For You
More Trending News
About INDP Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| INDP | - | - |
| Indaptus Therapeutics, Inc. | ||